<
>
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
Optimizing outcomes and efficiency: iCAD’s world-class solutions for the early detection and treatment of cancer
May 12, 2022
iCAD to Present at the Spring Into Action – Best Ideas Virtual Investor Conference on May 17th, 2022
May 11, 2022
iCAD Reports Financial Results for First Quarter Ended March 31, 2022
April 28, 2022
iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Clinical and IT Experts from Wake Radiology
» View All News »
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
<
>